Jason W Pyrdol

5PUBLICATIONS
35CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 09, 2026
The CARM1 epigenetic enzyme inhibits cross-presenting dendritic cell function in cancer immunity.

|Feb 22, 2023
Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell-Secreted Cytokines.

Yoshinaga Ito, Deng Pan, Wubing Zhang

|Mar 12, 2021
CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor Cells and T Cells.

Sushil Kumar, Zexian Zeng, Archis Bagati

|Mar 27, 2020
Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells.

Lucas Ferrari de Andrade, Sushil Kumar, Adrienne M Luoma

|Mar 31, 2018
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity.

Lucas Ferrari de Andrade, Rong En Tay, Deng Pan

Pageof 1

Frequent Collaborators

4 joint publications

Kai W Wucherpfennig

2 joint publications

Xixi Zhang

2 joint publications

John G Doench

2 joint publications

Yoshinaga Ito